Last reviewed: June 30, 2026
Last updated: June 30, 2026
Written by:
Jay Hastings,
CEO of PlexusDx
Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.
Medically reviewed by:
Jayden Lee, PharmD, EMBA
Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.
This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.
GLP-1 receptor agonists like semaglutide have revolutionized weight management, but questions about fertility and pregnancy safety are common among patients of reproductive age. Current evidence suggests that semaglutide does not directly impair ovulation or male fertility, though pregnancy planning with any medication requires careful discussion with your healthcare provider.
How Semaglutide Affects Reproductive Health
Semaglutide works on glucagon-like peptide-1 receptors throughout the body, slowing stomach emptying and reducing appetite signals in the brain. Animal studies have not shown direct damage to reproductive organs or hormone pathways at therapeutic doses, though long-term human fertility studies remain limited. Weight loss itself often improves ovulatory function in people with obesity, potentially enhancing rather than hindering conception odds.
The medication is not absorbed systemically in meaningful amounts when taken orally, and injected semaglutide clears the body within one to two weeks after your last dose. This short half-life means stopping the medication well before conception attempts can minimize fetal exposure during critical early pregnancy windows. Rapid weight loss in the months before conception may require dosage adjustments or temporary pause periods agreed upon with your care team.
Pregnancy Planning Timeline and Medication Discontinuation
Medical consensus recommends stopping semaglutide at least two to three months before actively trying to conceive, allowing the drug to fully clear your system and stabilize your metabolic baseline. This washout period also permits assessment of how weight regain or stabilization affects your overall health and readiness for pregnancy. Your PlexusDx provider can map a personalized tapering schedule that avoids rebound hunger and supports continued healthy habits during this transition.
If you become pregnant unexpectedly while on semaglutide, notify your healthcare provider immediately rather than stopping abruptly. Sudden medication discontinuation can trigger rapid appetite rebound and weight gain, creating metabolic stress during early pregnancy. Your clinical team will guide you on safe transition options and monitor both your weight stability and fetal development throughout the first trimester.
Clinical Evidence on GLP-1 Use and Fertility Outcomes
Published fertility studies involving GLP-1 users remain sparse, but existing data from patients who became pregnant while on or shortly after semaglutide show no increased rates of miscarriage, birth defects, or neonatal complications. Large diabetes trials with longer exposure histories have not flagged reproductive safety concerns, though these populations differ from weight-loss-focused patients. Ongoing registries continue to collect pregnancy outcomes in GLP-1 users to strengthen future guidance.
Weight loss of 5 to 15 percent body weight—the range typical with semaglutide therapy—is associated with improved insulin sensitivity, more regular menstrual cycles, and higher ovulation rates in people with polycystic ovary syndrome and obesity-related infertility. This improvement in metabolic and reproductive health may offset any theoretical concerns, making semaglutide a net positive for fertility planning when used strategically before conception attempts.
Personalized Fertility Support with PlexusDx Precision Peptide Testing
PlexusDx offers the Precision Peptide Genetic Test ($99 add-on after your first treatment month), which maps 14 metabolic pathways and 49 peptides linked to weight regulation and reproductive health. Testing identifies your genetic predispositions in appetite control, insulin signaling, and metabolic recovery—insights that inform whether semaglutide or tirzepatide will work best for your fertility timeline and long-term health goals. Understanding your unique peptide genetics helps your PlexusDx provider design a medication pause and conception plan tailored to your biology.
Key genetic variants such as GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 influence how your body responds to GLP-1 therapy and weight loss rebound risk. Patients with certain variants may experience slower or faster weight regain after stopping medication, affecting the ideal timing to begin conception attempts. This personalized roadmap empowers you to make evidence-based decisions about your fertility and medication schedule months in advance.
How Your Genetics Influence GLP-1 Response
Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — influence how your body processes these medications, how much weight you lose, and how you tolerate side effects. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights to match each patient to the right medication, dose, and lifestyle protocol for their biology. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month of treatment) gives your provider precise insight into your peptide genetic predispositions before the first prescription is written.
Access Personalized GLP-1 Care Through PlexusDx
PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection starts at $149/mo. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.
Frequently Asked Questions
Is it safe to become pregnant while actively taking semaglutide?
Becoming pregnant while on semaglutide is not ideal, and discontinuation is recommended. If unplanned pregnancy occurs, do not stop abruptly; contact your healthcare provider immediately for a safe transition plan. Stopping suddenly can trigger metabolic rebound and appetite dysregulation during a critical pregnancy window.
How long after stopping semaglutide can I safely try to conceive?
Most guidelines suggest waiting two to three months after your last dose to allow full clearance and metabolic stabilization before actively trying to conceive. This timeline also permits assessment of weight stability and adjustment of any lifestyle supports needed during pregnancy. Your PlexusDx provider can customize this schedule based on your individual health profile.
Will stopping semaglutide cause rapid weight gain that harms fertility?
Stopping semaglutide does often trigger appetite rebound and some weight regain, but gradual weight changes over several months do not significantly impair fertility in most cases. Maintaining healthy nutrition, regular movement, and stress management during this transition helps minimize rebound while supporting hormonal balance needed for conception.
Can semaglutide injection improve fertility if I have obesity-related infertility?
Yes, semaglutide injection often improves fertility outcomes in people with obesity and irregular cycles, particularly those with PCOS. Weight loss of 5 to 15 percent can restore ovulation and menstrual regularity, but discontinuation before conception attempts is still recommended per current clinical guidance. PlexusDx semaglutide injection starts at $149/mo with no your dose may need to go up - your price won't adjusts.
Does PlexusDx genetic testing help plan my fertility timeline?
Yes, the PlexusDx Precision Peptide Genetic Test identifies genetic variants affecting appetite rebound and metabolic recovery after stopping GLP-1 therapy. Understanding your FTO, MC4R, and GLP1R variants helps predict how quickly weight regain may occur, informing the ideal window to begin conception attempts while maintaining metabolic health.
Related Reading
Pricing and availability current as of June 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.
Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.
Medical and Editorial Standards
Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.
Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.
Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.
Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.
Share:
Optimizing Your Health Journey: How Often Do You Have to Take Ozempic?
Mastering Your Health Journey: How to Take an Ozempic® Shot Safely and Effectively